Covalently tethering siRNA to hydrogels for localized, controlled release and gene silencing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31489374.
- Also identified by DOI 10.1126/sciadv.aax0801 and PMC identifier 6713499.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Small interfering RNA (siRNA) has found many applications in tissue regeneration and disease therapeutics. Effective and localized siRNA delivery remains challenging, reducing its therapeutic potential. Here, we report a strategy to control and prolong siRNA release by directly tethering transfection-capable siRNA to photocrosslinked dextran hydrogels. siRNA release is governed via the hydrolytic degradation of ester and/or disulfide linkages between the siRNA and hydrogels, which is independent of hydrogel degradation rate. The released siRNA is shown to be bioactive by inhibiting protein expression in green fluorescent protein-expressing HeLa cells without the need of a transfection agent. This strategy provides an excellent platform for controlling nucleic acid delivery through covalent bonds with a biomaterial and regulating cellular gene expression, which has promising potential in many biomedical applications.
Medical subject headings
- Delayed-Action Preparations
- Gene Silencing
- Hydrogels
- RNA, Small Interfering